190 related articles for article (PubMed ID: 19275560)
21. DNA repair mechanisms in eukaryotes: Special focus in Entamoeba histolytica and related protozoan parasites.
López-Camarillo C; Lopez-Casamichana M; Weber C; Guillen N; Orozco E; Marchat LA
Infect Genet Evol; 2009 Dec; 9(6):1051-6. PubMed ID: 19591963
[TBL] [Abstract][Full Text] [Related]
22. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
Ali V; Nozaki T
Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
[TBL] [Abstract][Full Text] [Related]
23. Toltrazuril effective against a broad spectrum of protozoan parasites.
Mehlhorn H; Schmahl G; Haberkorn A
Parasitol Res; 1988; 75(1):64-6. PubMed ID: 3144713
[No Abstract] [Full Text] [Related]
24. Drugs targeting parasite lysosomes.
Doyle PS; Sajid M; O'Brien T; Dubois K; Engel JC; Mackey ZB; Reed S
Curr Pharm Des; 2008; 14(9):889-900. PubMed ID: 18473838
[TBL] [Abstract][Full Text] [Related]
25. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
26. [Drugs for protozoan diseases].
Ohta N
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():380-3. PubMed ID: 17455649
[No Abstract] [Full Text] [Related]
27. Clearing or subverting the enemy: Role of autophagy in protozoan infections.
Ghartey-Kwansah G; Aboagye B; Adu-Nti F; Opoku YK; Abu EK
Life Sci; 2020 Apr; 247():117453. PubMed ID: 32088215
[TBL] [Abstract][Full Text] [Related]
28. Structure-based ligand design and the promise held for antiprotozoan drug discovery.
Hunter WN
J Biol Chem; 2009 May; 284(18):11749-53. PubMed ID: 19103598
[TBL] [Abstract][Full Text] [Related]
29. Drug target identification in protozoan parasites.
Müller J; Hemphill A
Expert Opin Drug Discov; 2016 Aug; 11(8):815-24. PubMed ID: 27238605
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors.
Rodrigues JC; de Souza W
Curr Pharm Des; 2008; 14(9):925-38. PubMed ID: 18473841
[TBL] [Abstract][Full Text] [Related]
31. Apicomplexan plastids as drug targets.
McFadden GI; Roos DS
Trends Microbiol; 1999 Aug; 7(8):328-33. PubMed ID: 10431206
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.
Harder A; Greif G; Haberkorn A
Parasitol Res; 2001 Sep; 87(9):785-6. PubMed ID: 11570567
[TBL] [Abstract][Full Text] [Related]
33. The plant-type ferredoxin-NADP+ reductase/ferredoxin redox system as a possible drug target against apicomplexan human parasites.
Seeber F; Aliverti A; Zanetti G
Curr Pharm Des; 2005; 11(24):3159-72. PubMed ID: 16178751
[TBL] [Abstract][Full Text] [Related]
34. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
[TBL] [Abstract][Full Text] [Related]
35. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
Soldati D
Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
[No Abstract] [Full Text] [Related]
36. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2176-228. PubMed ID: 22414104
[TBL] [Abstract][Full Text] [Related]
37. [Target points of antiparasitic drugs].
Boczoń K
Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
[No Abstract] [Full Text] [Related]
38. New drugs needed for tropical diseases.
Sansom C
Lancet Infect Dis; 2002 Mar; 2(3):134. PubMed ID: 11944180
[No Abstract] [Full Text] [Related]
39. The plastid-like organelle of apicomplexan parasites as drug target.
Wiesner J; Reichenberg A; Heinrich S; Schlitzer M; Jomaa H
Curr Pharm Des; 2008; 14(9):855-71. PubMed ID: 18473835
[TBL] [Abstract][Full Text] [Related]
40. The proteasome as a target for protozoan parasites.
Xie SC; Dick LR; Gould A; Brand S; Tilley L
Expert Opin Ther Targets; 2019 Nov; 23(11):903-914. PubMed ID: 31679410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
